313 related articles for article (PubMed ID: 17608509)
1. Identification of differentially secreted biomarkers using LC-MS/MS in isogenic cell lines representing a progression of breast cancer.
Mbeunkui F; Metge BJ; Shevde LA; Pannell LK
J Proteome Res; 2007 Aug; 6(8):2993-3002. PubMed ID: 17608509
[TBL] [Abstract][Full Text] [Related]
2. The cancer secretome, current status and opportunities in the lung, breast and colorectal cancer context.
Schaaij-Visser TB; de Wit M; Lam SW; Jiménez CR
Biochim Biophys Acta; 2013 Nov; 1834(11):2242-58. PubMed ID: 23376433
[TBL] [Abstract][Full Text] [Related]
3. Mass spectrometry (LC-MS/MS) identified proteomic biosignatures of breast cancer in proximal fluid.
Whelan SA; He J; Lu M; Souda P; Saxton RE; Faull KF; Whitelegge JP; Chang HR
J Proteome Res; 2012 Oct; 11(10):5034-45. PubMed ID: 22934887
[TBL] [Abstract][Full Text] [Related]
4. Proteomic Analysis of Urine to Identify Breast Cancer Biomarker Candidates Using a Label-Free LC-MS/MS Approach.
Beretov J; Wasinger VC; Millar EK; Schwartz P; Graham PH; Li Y
PLoS One; 2015; 10(11):e0141876. PubMed ID: 26544852
[TBL] [Abstract][Full Text] [Related]
5. Comparative membrane proteomics analyses of breast cancer cell lines to understand the molecular mechanism of breast cancer brain metastasis.
Peng W; Zhang Y; Zhu R; Mechref Y
Electrophoresis; 2017 Sep; 38(17):2124-2134. PubMed ID: 28523741
[TBL] [Abstract][Full Text] [Related]
6. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
[TBL] [Abstract][Full Text] [Related]
7. Comparative serum proteome analysis of human lymph node negative/positive invasive ductal carcinoma of the breast and benign breast disease controls via label-free semiquantitative shotgun technology.
Hu X; Zhang Y; Zhang A; Li Y; Zhu Z; Shao Z; Zeng R; Xu LX
OMICS; 2009 Aug; 13(4):291-300. PubMed ID: 19624269
[TBL] [Abstract][Full Text] [Related]
8. Quantitative Secretomic Analysis Identifies Extracellular Protein Factors That Modulate the Metastatic Phenotype of Non-Small Cell Lung Cancer.
Hu R; Huffman KE; Chu M; Zhang Y; Minna JD; Yu Y
J Proteome Res; 2016 Feb; 15(2):477-86. PubMed ID: 26736068
[TBL] [Abstract][Full Text] [Related]
9. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.
Bouchal P; Roumeliotis T; Hrstka R; Nenutil R; Vojtesek B; Garbis SD
J Proteome Res; 2009 Jan; 8(1):362-73. PubMed ID: 19053527
[TBL] [Abstract][Full Text] [Related]
10. Identification of novel alternative splicing biomarkers for breast cancer with LC/MS/MS and RNA-Seq.
Zhang F; Deng CK; Wang M; Deng B; Barber R; Huang G
BMC Bioinformatics; 2020 Dec; 21(Suppl 9):541. PubMed ID: 33272210
[TBL] [Abstract][Full Text] [Related]
11. Identification of markers associated with highly aggressive metastatic phenotypes using quantitative comparative proteomics.
Terp MG; Lund RR; Jensen ON; Leth-Larsen R; Ditzel HJ
Cancer Genomics Proteomics; 2012; 9(5):265-73. PubMed ID: 22990106
[TBL] [Abstract][Full Text] [Related]
12. Proteomics approach to identify novel metastatic bone markers from the secretome of PC-3 prostate cancer cells.
Sung E; Kwon OK; Lee JM; Lee S
Electrophoresis; 2017 Oct; 38(20):2638-2645. PubMed ID: 28627741
[TBL] [Abstract][Full Text] [Related]
13. Identification of breast cancer metastasis-associated proteins in an isogenic tumor metastasis model using two-dimensional gel electrophoresis and liquid chromatography-ion trap-mass spectrometry.
Li DQ; Wang L; Fei F; Hou YF; Luo JM; ; Zeng R; Wu J; Lu JS; Di GH; Ou ZL; Xia QC; Shen ZZ; Shao ZM
Proteomics; 2006 Jun; 6(11):3352-68. PubMed ID: 16637015
[TBL] [Abstract][Full Text] [Related]
14. A proteomics study on human breast cancer cell lines by fluorogenic derivatization-liquid chromatography/tandem mass spectrometry.
Imai K; Ichibangase T; Saitoh R; Hoshikawa Y
Biomed Chromatogr; 2008 Nov; 22(11):1304-14. PubMed ID: 18821527
[TBL] [Abstract][Full Text] [Related]
15. Proteome profile of human breast cancer tissue generated by LC-ESI-MS/MS combined with sequential protein precipitation and solubilization.
Gong Y; Wang N; Wu F; Cass CE; Damaraju S; Mackey JR; Li L
J Proteome Res; 2008 Aug; 7(8):3583-90. PubMed ID: 18576677
[TBL] [Abstract][Full Text] [Related]
16. Identification of potential breast cancer markers in nipple discharge by protein profile analysis using two-dimensional nano-liquid chromatography/nanoelectrospray ionization-mass spectrometry.
Kurono S; Kaneko Y; Matsuura N; Oishi H; Noguchi S; Kim SJ; Tamaki Y; Aikawa T; Kotsuma Y; Inaji H; Matsuura S
Proteomics Clin Appl; 2016 May; 10(5):605-13. PubMed ID: 26970563
[TBL] [Abstract][Full Text] [Related]
17. [Promoter methylation and mRNA expression of APC gene in MCF10 breast cancer model].
Yang JL; Klinkebiel D; Boland MJ; Tang L; Christman JK
Zhonghua Bing Li Xue Za Zhi; 2006 Jan; 35(1):32-6. PubMed ID: 16608647
[TBL] [Abstract][Full Text] [Related]
18. An off-line high pH reversed-phase fractionation and nano-liquid chromatography-mass spectrometry method for global proteomic profiling of cell lines.
Wang H; Sun S; Zhang Y; Chen S; Liu P; Liu B
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jan; 974():90-5. PubMed ID: 25463202
[TBL] [Abstract][Full Text] [Related]
19. Mass spectrometry (LC-MS/MS) site-mapping of N-glycosylated membrane proteins for breast cancer biomarkers.
Whelan SA; Lu M; He J; Yan W; Saxton RE; Faull KF; Whitelegge JP; Chang HR
J Proteome Res; 2009 Aug; 8(8):4151-60. PubMed ID: 19522481
[TBL] [Abstract][Full Text] [Related]
20. Identification of proteins secreted by head and neck cancer cell lines using LC-MS/MS: Strategy for discovery of candidate serological biomarkers.
Ralhan R; Masui O; Desouza LV; Matta A; Macha M; Siu KW
Proteomics; 2011 Jun; 11(12):2363-76. PubMed ID: 21598386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]